Albireo Pharma OverviewAlbireo Pharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for ALBO.
Quarterly EBIT
-$34.66M
↑ 2.27% YoY
As of Sep 30, 2022
Annual EBIT (TTM)
-$112.62M
↑ 16.95% YoY
Trailing 12 months ending Sep 30, 2022
Albireo Pharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for ALBO.
As of Sep 30, 2022
Trailing 12 months ending Sep 30, 2022